Comparison

Gatifloxacin (hydrochloride) European Partner

Item no. HY-10581A-10mM
Manufacturer MedChem Express
CASRN 121577-32-0
Amount 10mM/1mL
Quantity options 10mM/1mL 1 g 500 mg 5 g
Category
Type Inhibitors
Specific against other
Purity 99.94
Formula C19H23ClFN3O4
Citations [1]Takei M, et al. Inhibitory activities of Gatifloxacin hydrochloride (AM-1155), a newly developed fluoroquinolone, against bacterial and mammalian type II topoisomerases.Antimicrob Agents Chemother. 1998 Oct;42(10):2678-81.<br>[2]Fukuda H, et al. Antibacterial activity of Gatifloxacin hydrochloride (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone-resistant mutants and the norA transformant of Staphylococcus aureus. Antimicrob Agents Chemother. 1998 Aug;42(8):1917-22.<br>[3]Yamada C, et al. Gatifloxacin hydrochloride acutely stimulates insulin secretion and chronically suppresses insulin biosynthesis. Eur J Pharmacol. 2006 Dec 28;553(1-3):67-72. Epub 2006 Sep 28.<br>[4]Daw-Garza A, et al. In vivo therapeutic effect of Gatifloxacin mesylate on BALB/c mice infected with Nocardia brasiliensis.Antimicrob Agents Chemother. 2008 Apr;52(4):1549-50.
Smiles CC1NCCN(C2=C(F)C=C3C(N(C4CC4)C=C(C(O)=O)C3=O)=C2OC)C1.Cl
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias AM-1155 (hydrochloride); BMS-206584 (hydrochloride); PD135432 (hydrochloride)
Similar products AM 1155 hydrochloride, BMS 206584-01 hydrochloride, PD 135432 hydrochloride
Available
Product Description
Gatifloxacin hydrochloride (AM-1155; BMS-206584; PD135432) is a potent fluoroquinolone antibiotic with broad-spectrum antibacterial activity. Gatifloxacin hydrochloride inhibits bacterial type II topoisomerases (IC50=13.8 μg/ml for S. aureus topoisomerase IV) and E. coli DNA gyrase (IC50 = 0.109 μg/ml)[1]. Gatifloxacin hydrochloride can be used to treat bacterial conjunctivitis in vivo.
StorageTemperature
4°C (Powder, sealed storage, away from moisture)
Shipping
Room Temperature
Manufacturers Applications
COVID-19-anti-virus
MolecularWeight
411.86
Clinical_Information
Launched
Manufacturers Research Area
Infection
Solubility
DMSO : 4 mg/mL (ultrasonic; warming; heat to 60°C)|H2O : 10 mg/mL (ultrasonic)
Manufacturers Target
Antibiotic; Bacterial; Topoisomerase
Isoform
Quinolone; Topo II
Pathway
Anti-infection; Cell Cycle/DNA Damage

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10mM/1mL
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close